- title: General Information
  type: map
  contents:
    - name: Full Name
      value: Zehua Wang (Zack Wang)
    - name: Date of Birth
      value: 23rd May 2000
    - name: Languages
      value: English (Professional Proficiency), Chinese (Native), Cantonese, Japanese

- title: Education
  type: time_table
  contents:
    - title: PhD Candidate in Pharmacology
      institution: The University of Auckland, New Zealand
      year: 2025-Present
      description:
        - "Developing population PK/PD models for anti-amyloid antibodies (lecanemab/donanemab) in Alzheimer's disease"
        - "Quantifying disease-modifying effects versus symptomatic relief using longitudinal biomarker modeling"
        - "Identifying key covariates (ApoE Îµ4 genotype, BBB permeability) for personalized dosing optimization"
        - "Prospective clinical study on exposure-response relationships in Chinese AD cohort (data collection phase)"

    - title: Master of Pharmacokinetics
      institution: China Pharmaceutical University, China
      year: 2025
      description:
        - "Thesis: Mechanistic modeling of antibody-drug conjugates and CNS drug transport pathology"
        - "Developed first-in-class PBPK-PD model for trastuzumab deruxtecan and sacituzumab govitecan predicting efficacy and interstitial lung disease risk"
        - "Discovered novel mechanisms of blood-brain barrier transporter dysregulation in hepatic encephalopathy"
        - "Elucidated venlafaxine-induced neuropsychiatric adverse effects via PI3K/AKT/mTOR-COMT-epigenetic axis"
        - "Led industry-sponsored Phase I NSAID clinical pharmacometrics study using WinNonlin and R"

    - title: Bachelor of Pharmaceutical Engineering
      institution: Shandong First Medical University, China
      year: 2022
      description:
        - "Synthesis and characterization of metal-organic framework-derived antibacterial carbon materials"
        - "Performance optimization of gradient graphene sponges for water purification applications"

- title: Publications
  type: list
  contents:
    - "Wang Z, et al. Whole-body PBPK-PD model predicting pharmacokinetics, efficacy and pulmonary toxicity of topoisomerase inhibitor antibody-drug conjugates. European Journal of Pharmaceutical Sciences (Under Revision) - Awarded Excellent Poster, 14th National Drug Metabolism Conference"
    - "Zhi H, Wang Z, et al. Chronic liver injury induces cerebral carnitine deficiency through downregulation of blood-brain barrier organic cation transporters OCT1/2 and OCTN2. Drug Metabolism and Disposition. 2025;53(5):100072"
    - "Zhu X, Wang Z, et al. Physiologically-based pharmacokinetic modeling of neuroprotective agent SPT-07A using in vitro-in vivo extrapolation across species. Pharmaceutics. 2024;16(12):1596"
    - "Zhi H, et al. Renal OCT2/MATE1 suppression in acute liver injury increases metformin systemic exposure and toxicity risk. Biomedicines. 2023;11(23):3314"
    - "Qian L, et al. Venlafaxine upregulates cerebral catechol-O-methyltransferase via PI3K/AKT/mTOR signaling leading to methyl donor depletion and histone hypomethylation. Research Square Preprint. 2023"

- title: Technical Proficiencies
  type: nested_list
  contents:
    - title: Computational Pharmacometrics
      items:
        - "Population PK/PD: Nonlinear mixed-effects modeling (NONMEM, Monolix)"
        - "PBPK Modeling: Cross-species scaling (PK-Sim, Berkeley Madonna)"
        - "Quantitative Systems Pharmacology: Mechanism-based disease progression modeling"
        - "Global Sensitivity Analysis: Sobol' method for covariate identification"
    - title: Bioanalytical Techniques
      items:
        - "HPLC-MS quantification: Tissue distribution studies"
        - "Biomolecular interaction analysis: SPR, MST, BLI"
        - "Molecular biology: Western blot, qPCR, confocal microscopy"
    - title: Statistical Computing
      items:
        - "R: Pharmacometric workflow implementation"
        - "Python: Machine learning for biomarker discovery"
        - "SPSS: Clinical data analysis"

- title: Honors and Awards
  type: time_table
  contents:
    - year: 2025
      items:
        - "Outstanding Graduate, China Pharmaceutical University (Top 3% of cohort)"
    - year: 2024
      items:
        - "Exploring the World Scholarship for International Research"
    - year: 2022-2025
      items:
        - "Outstanding League Member (3 consecutive years)"
        - "Academic Excellence Scholarship (3 awards)"
    - year: 2022
      items:
        - "Outstanding Graduate, Shandong First Medical University"

- title: Research Interests
  type: nested_list
  contents:
    - title: Pharmacometrics & Quantitative Pharmacology
      items:
        - "Mechanistic PK/PD modeling of biologics and ADCs"
        - "Model-informed drug development for regulatory decision making"
        - "Virtual clinical trial simulation for dose optimization"
    - title: Neuropharmacology & Blood-Brain Barrier
      items:
        - "Transporter-mediated CNS drug delivery"
        - "Peripheral organ pathology effects on brain pharmacokinetics"
        - "Disease-modifying therapy development for neurodegeneration"
    - title: Translational Drug Development
      items:
        - "Cross-species PBPK scaling from preclinical to clinical"
        - "Quantitative prediction of target-mediated drug disposition"
        - "Risk mitigation strategies for antibody-conjugate toxicity"

- title: Professional Development
  type: time_table
  contents:
    - year: 2023-2024
      items:
        - "Artificial Intelligence and Cloud Computing (Columbia University)"
        - "Emerging Biotechnology and Global Governance (Tsinghua University)"
        - "Big Data Applications in Public Health (Johns Hopkins University)"
    - year: 2024
      items:
        - "Advanced Probability and Statistical Theory (Bocconi University)"
        - "Data Science for Business Analytics (University of Virginia)"
